Month: February 2007
-
By Christopher P. Singer A notice in the Federal Register published on Friday, February 16, 2007 announced certain rule changes to the Patent Cooperation Treaty (PCT) that will take effect on April 1, 2007. The changes will (a) restore an Applicant’s right to make a priority claim under certain circumstances, and (b) allow…
-
By Kevin Noonan The Indonesian health ministry agreed to resume supplying samples of H5N1 influenza virus to the World Health Organization, having received assurances from the agency that affordably flu vaccines would be made available to Indonesia and other poor countries, The New York Times reported Saturday. Earlier, Indonesia had suspended these supplies,…
-
By Mark Chael 3M, headquartered in Minnesota, recently announced that it has acquired the U.K. biotechnology firm, Acolyte Biomedica Ltd. According to the press release dated February 14, 2007, this acquisition is a natural extension of 3M’s infection prevention technologies and 3M expects to continue expanding their diagnostic testing platforms through complementary acquisitions…
-
February 20, 2007 – "Potential Licensing Responses to MedImmune: The Supreme Court's Latest Word on Declaratory Judgment Actions Challenging Patent Validity" (ABA CLE) February 22, 2007 – Intellectual Property Valuation Teleconference (National Constitution Center) February 23, 2007 – John Marshall Law School 51st Annual IP Law Conference – Chicago, IL February 27-28, 2007 – Patent…
-
By Kevin Noonan Much has been written in the comments to my response to Michael Crichton’s recent OpEd piece in The New York Times. In order to open up the debate to those who haven’t read the comments, here is a thought experiment: You isolate a petrochemical with excellent lubrication qualities. It is…
-
By Jason Derry The Biotech Feature of the Month at PipelineReview.com provides an overview and discussion relating to the current state of biogenerics in the industry and marketplace. The Feature specifically discusses the major classes of biologics currently having branded products, including erythropoietin, somatotropin, interferon, granulocyte colony stimulating factor (G-CSF), insulin, and thrombolytics. …
-
By Christopher P. Singer In a February 14, 2006 press release, Idera Pharmaceuticals, Inc. announced that U.S. Patent No. 7,176,296, titled "Modulation of Oligonucleotide CpG-Mediated Immune Stimulation by Positional Modification of Nucleosides," has been granted by the U.S. Patent Office. According to Idera, the patent covers a series of compounds that comprise modifications…
-
The Center for Intellectual Property Law at the John Marshall Law School in Chicago, Illinois will be holding its annual Intellectual Property Law Conference on February 23, 2007. The morning session of the conference will focus on recent developments in patent, trademark, copyright, and trade secret law as well as electronic discovery under the new…
-
Law Seminars International's second annual conference on Complex IP and Technology Transactions will be held on March 21-22, 2007 in Chicago, Illinois. The conference will focus on the business factors that must be considered and the legal issues that can arise in complex licensing transactions. In particular, the conference will offer presentations on the following…
-
The National Constitution Center is offering an audio conference entitled: "Intellectual Property Valuation: What's Your IP Worth?" on February 22, 2007 from 1:00-2:00 PM (EST). Speaker John O'Malley of Volpe and Koenig, P.C. will discuss specific practices for conducting effective IP due diligence and performing routine IP audits. In particular, the conference will cover the…
Patent Docs 